prostate cancer

Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Fri, 11/18/11 - 11:37 am
Dendreon
Provenge
JNJ
prostate cancer
Isoray: Impressive 98% Success Treating Prostate Cancer
Thu, 11/17/11 - 10:36 pm
IsoRay
cancer
prostate cancer
patient
Ziopharm Oncology presents preclinical data for darinaparsin
Yahoo/Fly on the Wall
Mon, 11/14/11 - 10:54 am
Ziopharm
darinaparsin
prostate cancer
Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC
Yahoo/BusinessWire
Sun, 11/13/11 - 12:06 pm
prostate cancer
cabozantinib
bone cancer
Exelixis
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tue, 11/8/11 - 11:00 am
prostate cancer
Dendreon
Provenge
Zytiga
JNJ
Medivation
MVD 3100
Exelixis
cabozantinib
Curtirsen
Teva Pharmaceuticals
OncoGenex
Adamis Pharmaceuticals Corp. (ADMP) is “One to Watch”
Beacon Equity Research
Sun, 11/6/11 - 12:14 pm
Adamis Pharmaceuticals
TeloB-VAX
prostate cancer
cancer vaccines
Medivation Up 140% In One Day, While Dendreon Gets Quartered
Seeking Alpha
Sat, 11/5/11 - 02:35 pm
Medivation
Dendreon
Provenge
MDV3100
prostate cancer
Medivation rockets 120% on drug study
Marketwatch
Thu, 11/3/11 - 12:21 pm
Medivation
prostate cancer
MDV3100
Exelixis clashes with FDA over prostate cancer study, shares tank
Fierce Biotech
Tue, 11/1/11 - 11:05 am
prostate cancer
FDA
Exelixis
cabozantinib
Dendreon to amp up DTC support for Provenge
Fierce Pharma
Wed, 10/12/11 - 10:43 am
DTC
Provenge
prostate cancer
Dendreon
Dendreon's Provenge: Some On The Street Doth Protest Too Much
Seeking Alpha
Mon, 10/10/11 - 12:02 pm
Provenge
prostate cancer
Dendreon
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
The USPSTF Finally Acts on Prostate Cancer Screening Test
Sat, 10/8/11 - 11:35 am
prostate cancer
screening
Dendreon Revisited: What Management Is Saying About Provenge
Seeking Alpha
Tue, 10/4/11 - 10:44 am
Dendreon
prostate cancer
Provenge
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
Mon, 09/26/11 - 11:39 am
Bayer
prostate cancer
Algeta
Amgen
Xgeva
Exelixis
Alpharadin
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Sat, 09/24/11 - 01:26 pm
Bone metastases
prostate cancer
Alpharadin
Algeta
Bayer
Dendreon Shareholders May Yet Have The Last Laugh
Seeking Alpha
Thu, 09/22/11 - 02:26 pm
Dendreon
Provenge
prostate cancer
shareholders
Seattle Genetics
Analysis: New drugs drive prostate cancer market
Yahoo/AP
Mon, 09/19/11 - 06:08 pm
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
Amgen Wins Expanded U.S. Approval for Bone-Strengthening Drug
Bloomberg
Mon, 09/19/11 - 12:18 pm
FDA
Amgen
Prolia
prostate cancer
breast cancer
Exelixis' Shares Plunged: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:53 pm
Exelixis
cabozanitib
prostate cancer

Pages